Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nagy Mekhail

Pain Medicine Cleveland, OH Medical Doctor

NPI 1306936489 CMS profile 58903

9500 Euclid Ave, Cleveland, OH 44195

Open in the dashboard

General payments

$510,506

207 records reported · program years 2019–2025

Research payments

$360,517

Paid to them · 67 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$176,489 paid to institutions, not to them · program years 2021–2023

Through program year 2025, Nagy Mekhail of Cleveland, OH is reported in the CMS Open Payments database as having received $510,506 across 207 general payments and $360,517 in research payments paid to them. Separately, studies naming them as principal investigator received $176,489 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,474 19
2024 General $76,394 42
2024 Research $13,300 3
2023 General $144,330 38
2023 Research $59,675 9
2022 General $102,382 38
2022 Research $2,813 1
2021 General $20,362 26
2021 Research $54,726 12
2020 General $18,590 14
2020 Research $34,625 13
2019 General $132,974 30
2019 Research $195,378 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nagy Mekhail
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Nagy Mekhail were reported at $15,474. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Nagy Mekhail Pain Medicine median Middle half National median
2019 $132,974 $498 $126–$1,682 $163
2020 $18,590 $284 $80–$910 $114
2021 $20,362 $399 $112–$1,219 $132
2022 $102,382 $455 $137–$1,484 $149
2023 $144,330 $484 $128–$1,495 $160
2024 $76,394 $498 $131–$1,540 $164
2025 $15,474 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Saluda Medical Americas, Inc. $237,281 73 payments
  2. MML US, Inc. $114,615 72 payments
  3. Nevro Corp. $79,092 22 payments
  4. Relievant Medsystems, Inc. $42,631 9 payments
  5. Vertos Medical, Inc. $28,717 15 payments
  6. Abbott Laboratories $7,231 7 payments
  7. Boston Scientific Corporation $372 4 payments
  8. Spinal Simplicity, LLC $180 1 payment
  9. Avanos Medical $176 1 payment
  10. Stryker Corporation $170 1 payment
  11. Other $41 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $378,460 56 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $75,513 15 payments
  3. Travel and Lodging $48,574 60 payments
  4. Food and Beverage $7,960 76 payments
Products named General payments · program years 2019–2025
  1. Evoke SCS $169,835 49 payments
  2. ReActiv8 $114,615 72 payments
  3. Senza Spinal Cord Stimulation System $76,504 18 payments
  4. Evoke $67,446 24 payments
  5. Intracept $42,597 8 payments
  6. mild Device Kit Orthopedic $25,369 11 payments
  7. Neuromodulation Dspsbls and Accs $6,900 4 payments
  8. mild Device Kit Orthopedic $3,348 4 payments
  9. Senza $1,588 2 payments
  10. Omnia $1,000 2 payments
  11. Other $1,336 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Vertos Medical, Inc. $140,463 20 payments
  2. Saluda Medical Americas, Inc. $127,079 32 payments
  3. MML US, Inc. $72,975 12 payments
  4. Nevro Corp. $20,000 3 payments

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$42,260

Medicare's payments for the services billed

Medicare patients

169

Average age 74

Services billed

600

91 women, 78 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 38%
Chronic kidney disease 33%
Diabetes 28%
Ischemic heart disease 27%
Osteoporosis 24%
Cancer 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

274 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record